Eye drops for chronic dry eye after stem cell transplant
Part of Eyes & vision, Immune system & allergy clinical trials.
This trial tests an eye drop solution for people with chronic dry eye caused by graft-versus-host disease after a stem cell transplant. It aims to see if the drops can reduce eye discomfort and improve the eye surface.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have chronic dry eye due to graft-versus-host disease after a stem cell transplant.
- Your dry eye symptoms are at least moderate (for example, your OSDI score is 33 or higher).
- Your dry eye treatment has been stable for at least 30 days before starting the study.
- You do not have any active eye infection, recent eye surgery, or other eye conditions that could interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial provides access to an investigational eye drop solution for people with chronic dry eye caused by graft-versus-host disease (GVHD) after a stem cell or bone marrow transplant. The goal is to see if the drops can help relieve eye discomfort and improve vision-related quality of life.
This study tests whether a new eye drop (rhPRG4) can safely reduce dry eye symptoms caused by graft-versus-host disease (GVHD). It compares the active drops to an inactive placebo to see if they provide better relief.
This study looks at how an “ocular surface” condition can be identified using tests (biomarkers) and how a targeted treatment may help. You may qualify if you’re an adult receiving eye care at specific University of Maryland locations.
This study tests a new eye drop called CSB-001 for people with limbal stem cell deficiency (LSCD), a condition that damages the cornea. The goal is to see if the drops can help improve the health of the cornea and reduce inflammation.
This trial tests whether injecting stem cells around the eyes can help people with severe dry eye caused by graft-versus-host disease (GVHD) after a stem cell or bone marrow transplant. It aims to reduce eye pain and improve vision when standard treatments haven't worked.
This study looks at how common and how severe corneal nerve-related dryness is in people with chronic graft-vs-host disease (GVHD) after a stem cell transplant. It may help doctors understand which eye problems are most typical and how best to recognize them early.
Hear when a new oGVHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.